Who makes Cedilanid D?

Cedilanid D is developed by Novartis.

What development phase is Cedilanid D in?

Cedilanid D is FDA-approved (marketed).

What is the generic name of Cedilanid D?

DESLANOSIDE is the generic (nonproprietary) name of Cedilanid D.

Last reviewed 2026-04-20 · How we verify

Cedilanid D (DESLANOSIDE)

Novartis · FDA-approved approved Small molecule Quality 10/100

At a glance

Generic name	DESLANOSIDE
Sponsor	Novartis
Drug class	deslanoside
Target	Sodium/potassium-transporting ATPase
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved
First approval	1982

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cedilanid D CI brief — competitive landscape report
Cedilanid D updates RSS · CI watch RSS
Novartis portfolio CI